Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulka Vaishampayan

Showing results (31-40 of 176) with videos related to

Pageof 18
Sort By:
Prostate Cancer|March 25, 2015
Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer PatientsUlka Vaishampayan, Archana Thakur, Ritesh Rathore, et al.
JAMA Oncology|December 14, 2023
Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma: A ReviewAlireza Ghoreifi, Ulka Vaishampayan, Ming Yin, et al.
Cancer Causes & Control : CCC|October 25, 2003
Survival analysis of distant prostate cancer by decade (1973-1997) in the Detroit Metropolitan Surveillance, Epidemiology and End Results (SEER) Program registry: has outcome improved? (United States)Jill S Barnholtz-Sloan, Richard K Severson, Ulka Vaishampayan, et al.
Cancer Investigation|May 25, 2002
Outcome of relapsed non-Hodgkin's lymphoma patients after allogeneic and autologous transplantationUlka Vaishampayan, Chatchada Karanes, Wei Du, et al.
Kidney Cancer Journal : Official Journal of the Kidney Cancer Association|March 21, 2022
"PROBE"ing the Role of Cytoreductive Nephrectomy in Advanced Renal CancerHannah Bell, Brittney H Cotta, Simpa S Salami, et al.
Journal of Kidney Cancer and VHL|April 10, 2025
Patient Perspective on Medical Conditions Post Immune Checkpoint Therapy in Advanced Renal CarcinomaUlka Vaishampayan, Sumanta Pal, Sephora Dafinescu, et al.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2005
A single institution experience with concurrent capecitabine and radiation therapy in weak and/or elderly patients with urothelial cancerBhaumik Patel, Jeffrey Forman, Joseph Fontana, et al.
European Urology Focus|April 23, 2025
Defining the Role of Surgical Resection in Metastatic Renal Cell Carcinoma: A Mini ReviewSteven M Monda, Simpa S Salami, Ulka Vaishampayan, et al.
Frontiers in Oncology|September 2, 2014
Surgical excision of duodenal/pancreatic metastatic renal cell carcinomaEduardo Espinoza, Ali Hassani, Ulka Vaishampayan, et al.
Investigational New Drugs|October 6, 2021
Phase Ia dose escalation study of OBP-801, a cyclic depsipeptide class I histone deacetylase inhibitor, in patients with advanced solid tumorsElisabeth I Heath, Amy Weise, Ulka Vaishampayan, et al.
Pageof 18

Showing results (31-40 of 176) with videos related to

Sort By:
Pageof 18
Prostate Cancer|March 25, 2015
Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer PatientsUlka Vaishampayan, Archana Thakur, Ritesh Rathore, et al.
JAMA Oncology|December 14, 2023
Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma: A ReviewAlireza Ghoreifi, Ulka Vaishampayan, Ming Yin, et al.
Cancer Causes & Control : CCC|October 25, 2003
Survival analysis of distant prostate cancer by decade (1973-1997) in the Detroit Metropolitan Surveillance, Epidemiology and End Results (SEER) Program registry: has outcome improved? (United States)Jill S Barnholtz-Sloan, Richard K Severson, Ulka Vaishampayan, et al.
Cancer Investigation|May 25, 2002
Outcome of relapsed non-Hodgkin's lymphoma patients after allogeneic and autologous transplantationUlka Vaishampayan, Chatchada Karanes, Wei Du, et al.
Kidney Cancer Journal : Official Journal of the Kidney Cancer Association|March 21, 2022
"PROBE"ing the Role of Cytoreductive Nephrectomy in Advanced Renal CancerHannah Bell, Brittney H Cotta, Simpa S Salami, et al.
Journal of Kidney Cancer and VHL|April 10, 2025
Patient Perspective on Medical Conditions Post Immune Checkpoint Therapy in Advanced Renal CarcinomaUlka Vaishampayan, Sumanta Pal, Sephora Dafinescu, et al.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2005
A single institution experience with concurrent capecitabine and radiation therapy in weak and/or elderly patients with urothelial cancerBhaumik Patel, Jeffrey Forman, Joseph Fontana, et al.
European Urology Focus|April 23, 2025
Defining the Role of Surgical Resection in Metastatic Renal Cell Carcinoma: A Mini ReviewSteven M Monda, Simpa S Salami, Ulka Vaishampayan, et al.
Frontiers in Oncology|September 2, 2014
Surgical excision of duodenal/pancreatic metastatic renal cell carcinomaEduardo Espinoza, Ali Hassani, Ulka Vaishampayan, et al.
Investigational New Drugs|October 6, 2021
Phase Ia dose escalation study of OBP-801, a cyclic depsipeptide class I histone deacetylase inhibitor, in patients with advanced solid tumorsElisabeth I Heath, Amy Weise, Ulka Vaishampayan, et al.
Pageof 18